Literature DB >> 12032893

Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile.

Anna Wanahita1, Elizabeth A Goldsmith, Daniel M Musher.   

Abstract

Few modern studies have enumerated the conditions associated with leukocytosis. Our clinical experience has implicated Clostridium difficile infection in a substantial proportion of patients with leukocytosis. In a prospective, observational study of 400 inpatients with WBC counts of >/=15,000 cells/mm(3), we documented >/=1 infection in 207 patients (53%). Of these 207 patients, 97 (47%) had pneumonia, 60 (29%) had urinary tract infection, 34 (16%) had soft-tissue infection, and 34 (16%) had C. difficile infection. C. difficile infection was present in 25% of patients with WBC counts of >30,000 cells/mm(3) who did not have hematological malignancy. Other causes of leukocytosis in the 400 patients included physiological stress, in 152 patients (38%); medications or drugs, in 42 (11%); hematological disease, in 22 (6%); and necrosis or inflammation, in 22 (6%). C. difficile infection is a prominent cause of leukocytosis and this diagnosis should be considered for patients with WBC counts of >/=15,000 cells/mm(3), even in the absence of diarrheal symptoms.

Entities:  

Mesh:

Year:  2002        PMID: 12032893     DOI: 10.1086/340536

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Clostridium difficile-associated colitis.

Authors:  Mark W Hull; Paul L Beck
Journal:  Can Fam Physician       Date:  2004-11       Impact factor: 3.275

Review 3.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

4.  Clostridium difficile infection in fever patients with gynecological malignancies.

Authors:  Shintaro Yanazume; Akio Tokudome; Mika Fukuda; Shinichi Togami; Masaki Kamio; Shunichiro Ota; Hiroaki Kobayashi
Journal:  Cancer Rep (Hoboken)       Date:  2019-07-22

Review 5.  Clostridium difficile infection in the intensive care unit.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

Review 6.  Clostridium difficile.

Authors:  Scott Curry
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

7.  Clostridium difficile infection: emerging concepts and treatments.

Authors:  Thomas Mathew; Philip A Higginbottom
Journal:  Curr Gastroenterol Rep       Date:  2008-08

Review 8.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

9.  In recurrent C. difficile, the CRP response to the primary C. difficile infection predicts whether the same strain or a different strain will cause a second infection.

Authors:  Kangni Chen; Stephanie d'Arc; Naveen Setty; Kathy Bamford; Neil Fairweather; Jonathan Tyrrell-Price
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

10.  Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.

Authors:  Nagham Khanafer; Abdoulaye Touré; Cécile Chambrier; Martin Cour; Marie-Elisabeth Reverdy; Laurent Argaud; Philippe Vanhems
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.